Clinical Trials Logo

Severe Depression clinical trials

View clinical trials related to Severe Depression.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05957341 Not yet recruiting - Clinical trials for Major Depressive Disorder

pBFS Guided 20min Inter-session Interval rTMS Treatment for MDD

Start date: July 30, 2023
Phase: N/A
Study type: Interventional

The investigators aim to explore the efficacy and safety of rTMS therapies with different intervals between sessions for treating patients with moderate to severe depression.

NCT ID: NCT03380442 Not yet recruiting - Severe Depression Clinical Trials

Psilocybin and Depression

Psilo101
Start date: September 2018
Phase: Phase 2
Study type: Interventional

The main aim of the study is to investigate the possible long-term therapeutic effects of psilocybin on the symptoms of severe depression, as well as the brain mechanisms underlying these changes. Depression severity is assessed before and after (i.e., 1 week, 3 months and 6 months after) a single dose of psilocybin and compared to respective scores of a group receiving an active placebo, ketamine. Brain activity (using functional magnetic resonance imaging) is measured before and one week after drug administration in order to determine whether changes in brain networks related to emotional and self-referential processing correlate with any observed changes in depression scores. Further, blood samples will be obtained from the participants and analyzed in order to reveal gene expression and molecular level correlates underlying rapid antidepressant effects, and to identify biomarkers that predict treatment outcome.